Literature DB >> 29119412

Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.

Karn Wijarnpreecha1, Supavit Chesdachai2, Charat Thongprayoon3, Veeravich Jaruvongvanich4, Patompong Ungprasert5,6, Wisit Cheungpasitporn7.   

Abstract

BACKGROUND/
OBJECTIVES: Hepatic encephalopathy is the common manifestation of decompensated cirrhosis. The association between Helicobacter pylori (H. pylori) infection and hepatic encephalopathy has been shown in many epidemiologic studies. This meta-analysis was conducted to summarize all available studies to estimate the association between H. pylori infection and hepatic encephalopathy.
METHODS: A comprehensive literature review was conducted using MEDLINE and EMBASE database through March 2017 to identify studies that reported the association between H. pylori infection and hepatic encephalopathy. Effect estimates from the individual study were extracted and combined using random-effect, generic inverse variance method of DerSimonian and Laird.
RESULTS: Of 15,233 studies, eleven studies (four cross-sectional, four case-control, and three cohort studies) met the eligibility criteria and were included in the meta-analysis. The pooled OR of hepatic encephalopathy in patients with H. pylori infection was 1.73 (95% CI 1.09-2.73) when compared with the patients without H. pylori infection. The association between H. pylori and hepatic encephalopathy was not statistically significant after the sensitivity analysis, excluding those using ELISA alone, with a pooled OR of 1.92 (95% CI 0.91-4.05, I 2 = 62%). There was no publication bias of overall included studies assessed by the funnel plots and Egger's regression asymmetry test.
CONCLUSIONS: This study demonstrated a potential association between H. pylori infection and risk of hepatic encephalopathy. Future studies are required to assess the effect of chronicity of infection on the development of hepatic encephalopathy.

Entities:  

Keywords:  Campylobacter; Delirium; Helicobacter; Hepatic encephalopathy; Meta-analysis

Mesh:

Year:  2017        PMID: 29119412     DOI: 10.1007/s10620-017-4834-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Ammonia as a source of gastric hypoacidity in patients with uremia.

Authors:  C S LIEBER; A LEFEVRE
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

Review 2.  Minimal hepatic encephalopathy impairs quality of life.

Authors:  Swastik Agrawal; Sridharan Umapathy; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-04

3.  Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis.

Authors:  H Suto; T Azuma; S Ito; M Ohtani; M Dojo; Y Ito; Y Kohli; M Kuriyama
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.

Authors:  M Huber; M Rössle; V Siegerstetter; A Ochs; K Haag; M Kist; H E Blum
Journal:  Hepatogastroenterology       Date:  2001 Mar-Apr

Review 5.  Helicobacter pylori and extragastric diseases.

Authors:  Elisabetta Goni; Francesco Franceschi
Journal:  Helicobacter       Date:  2016-09       Impact factor: 5.753

6.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.

Authors:  M Romero-Gómez; F Boza; M S García-Valdecasas; E García; J Aguilar-Reina
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

7.  Prevalence of minimal hepatic encephalopathy in cirrhotic patients.

Authors:  Héctor Jesús Maldonado-Garza; Genaro Vázquez-Elizondo; Juan Obed Gaytán-Torres; Angel Ricardo Flores-Rendón; Martha Graciela Cárdenas-Sandoval; Francisco Javier Bosques-Padilla
Journal:  Ann Hepatol       Date:  2011-06       Impact factor: 2.400

Review 8.  Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review.

Authors:  Christian Schulz; Kerstin Schütte; Peter Malfertheiner
Journal:  J Clin Gastroenterol       Date:  2014-07       Impact factor: 3.062

9.  Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No. 275.

Authors:  G P Gubbins; T E Moritz; L S Marsano; R Talwalkar; C J McClain; C L Mendenhall
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

Review 10.  Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review.

Authors:  Raúl Herzog; María José Álvarez-Pasquin; Camino Díaz; José Luis Del Barrio; José Manuel Estrada; Ángel Gil
Journal:  BMC Public Health       Date:  2013-02-19       Impact factor: 3.295

View more
  5 in total

1.  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.

Authors:  Jannis Kountouras; Stergios A Polyzos; Panagiotis Katsinelos; Sotiris Anastasiadis; Dimitri Tzivras; Michael Doulberis; Ioannis Venizelos; Elizabeth Vardaka; Constantinos Kountouras; Georgia Deretzi
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

2.  Hepatic Encephalopathy and Helicobacter pylori.

Authors:  Antonio Ponzetto; Dino Vaira
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

3.  Relationship between Helicobacter pylori infection and osteoporosis: a systematic review and meta-analysis.

Authors:  Taiwu Wang; Xiang Li; Qi Zhang; Bingjie Ge; Jinhai Zhang; Lei Yu; Tongjian Cai; Yao Zhang; Hongyan Xiong
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

4.  Chinese guidelines on management of hepatic encephalopathy in cirrhosis.

Authors:  Xiao-Yuan Xu; Hui-Guo Ding; Wen-Gang Li; Ji-Dong Jia; Lai Wei; Zhong-Ping Duan; Yu-Lan Liu; En-Qiang Ling-Hu; Hui Zhuang; Chinese Society Of Hepatology; Chinese Medical Association
Journal:  World J Gastroenterol       Date:  2019-09-28       Impact factor: 5.742

5.  Electroacupuncture Synergistically Inhibits Proinflammatory Cytokine Production and Improves Cognitive Function in Rats with Cognitive Impairment due to Hepatic Encephalopathy through p38MAPK/STAT3 and TLR4/NF-κB Signaling Pathways.

Authors:  Jiling Huang; Zhigang Gong; Yingnan Kong; Yanwen Huang; Hui Wang; Yingjie Kang; Songhua Zhan
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-01       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.